Advertisement
Drug makers shouldn’t penalize patients who helped them profit, an oncologist argues
Radiogenomic signature could identify patients likely to benefit from targeted therapy
Addressing a patient’s addiction fears versus the need for pain relief
Emerging evidence regarding the genetic pathways involved in Scwachman-Diamond syndrome and Severe Congenital Neutropenia
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Characterizing endometrial cancer in young patients diagnosed before age 40
Focus is on inhibiting action of myeloid-derived suppressor cells
Socioeconomic factors play a role in time-to-surgery—including race, insurance status and facility type
Outcomes in youngest patients are mixed, reflecting clinical challenges
Helping cancer patients survive and thrive
This cell surface protein could be an immune checkpoint inhibition target
Advertisement
Advertisement